Human Immunodeficiency Virus Type 1 (HIV-1) antibody
Quick Overview for Human Immunodeficiency Virus Type 1 (HIV-1) antibody (ABIN2859502)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Protein A chromatography
-
Purity
- > 90 %.
-
Isotype
- IgG2
-
-
-
-
Application Notes
-
ELISA. Western blot (1/10 - 1/50). Successful use in Immunoflourescence was reported by some researchers. As thisdetection method has not been verified by the newest quality control, the application wasdeleted from the database. This does not necessarily exclude the use in such procedure.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 100 µg/mL (OD280 nm, E0.1% = 1.3)
-
Buffer
- 0.01 M PBS, pH 7.2 containing 0.09 % sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Human Immunodeficiency Virus Type 1 (HIV-1)
-
Alternative Name
- HIV-1
-
Target Type
- Virus
-
Background
- HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1
Target
-